Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial

Trials
Michael C TannerPatrick Haubruck

Abstract

Treatment of non-union remains challenging and often necessitates augmentation of the resulting defect with an autologous bone graft (ABG). ABG is limited in quantity and its harvesting incurs an additional surgical intervention leaving the risk for associated complications and morbidities. Therefore, artificial bone graft substitutes that might replace autologous bone are needed. S53P4-type bioactive glass (BaG) is a promising material which might be used as bone graft substitute due to its osteostimulative, conductive and antimicrobial properties. In this study, we plan to examine the clinical effectiveness of BaG as a bone graft substitute in Masquelet therapy in comparison with present standard Masquelet therapy using an ABG with tricalciumphosphate to fill the bone defect. This randomized controlled, clinical non-inferiority trial will be carried out at the Department of Orthopedics and Traumatology at Heidelberg University. Patients who suffer from tibial or femoral non-unions with a segmental bone defect of 2-5 cm and who are receiving Masquelet treatment will be included in the study. The resulting bone defect will either be filled with autologous bone and tricalciumphosphate (control group, N = 25) or BaG (S53P4) (stud...Continue Reading

References

Jan 26, 1999·Clinical Orthopaedics and Related Research·T A Einhorn
Dec 6, 2003·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Ph PelissierJ Amedee
Feb 13, 2004·The Journal of Trauma·Florian HoegelNorbert P Suedkamp
Sep 1, 2005·Clinical Orthopaedics and Related Research·Laurent AudigéThomas P Rüedi
Mar 3, 2007·The Journal of Bone and Joint Surgery. American Volume·William G De LongTracy Watson
Sep 23, 2008·Injury·Peter V GiannoudisDavid Marsh
Nov 26, 2009·The Orthopedic Clinics of North America·Alain C Masquelet, Thierry Begue
Mar 10, 2010·Journal of Orthopaedic Trauma·Hans Christoph PapePhilipp Kobbe
Jan 19, 2011·International Orthopaedics·George CoxPeter V Giannoudis
Feb 15, 2011·International Journal of Environmental Research and Public Health·Jimmy Efird
Mar 19, 2011·BMC Bioinformatics·Xavier RobinMarkus Müller
Mar 23, 2011·Acta Biomaterialia·Mohamed N RahamanAntoni P Tomsia
Sep 10, 2011·Journal of Orthopaedic Trauma·Heather A VallierBrendan M Patterson
Oct 25, 2011·International Journal of Surgery·Kenneth F SchulzUNKNOWN CONSORT Group
Jan 17, 2012·Orthopaedics & Traumatology, Surgery & Research : OTSR·C KargerUNKNOWN French Society of Orthopaedic Surgery and Traumatology (SoFCOT)
Jan 11, 2013·BMJ : British Medical Journal·An-Wen ChanDavid Moher
Feb 3, 2015·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Per BosemarkMagnus Tägil
Oct 16, 2015·The Journal of Antimicrobial Chemotherapy·Monica BortolinLorenzo Drago
Dec 17, 2015·Zeitschrift für Orthopädie und Unfallchirurgie·G Schmidmaier, A Moghaddam
Apr 3, 2016·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Christian FischerMarc-André Weber
Jun 9, 2016·Journal of Materials Science. Materials in Medicine·Fabian WesthauserArash Moghaddam
Jul 27, 2017·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·W J MetsemakersS Nijs
Oct 12, 2017·International Orthopaedics·Shunsuke AkihoTakuaki Yamamoto

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation

Software Mentioned

Masquelet
SampleSize4ClinicalTrials
R
ggplot2
pROC

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.